Digital nutrition start-up raises $8M

A provider of nutrition-related data services and analytics technology has raised $8 million to expand its services.

Nutrino has completed its latest Series A funding round to help expands its services across the digital health sector and foster additional partnerships in an effort to help people living with diabetes.

Nutrino’s platform includes a food database to enable companies within digital health to improve their products and programmes and to better understand populations and eating patterns. The company will use the funding to develop its database, which collates data from millions of food items across the world.

The company’s platform uses machine learning and AI to understand individual responses to particular foods via feedback from wearables and other data-points. Data allows Nutrino to define a person’s ‘FoodPrint’ to give people greater control to manage chronic diseases, weight and wellbeing.

Ziv Ben Barouch, managing partner of Pereg Ventures, one the investors, said: “Digital Health is predicted to be worth several hundreds of billions in the coming decade. With skyrocketing consumer demand for increased information about what they eat and growing health awareness, nutrition data is the largest untapped sector of this industry, and Nutrino is perfectly positioned to address this opportunity.”

Nutrino CEO Yael Glassman said: “Our proprietary technology, FoodPrint, uncovers the previously invisible connections between people and their food. Nutrino is where data meets nutrition, and as we’ve demonstrated in our work with multinational partners around nutrition and diabetes, the opportunity is vast. This funding round will enable us to significantly expand our commercial reach.”

Reece Armstrong is a reporter for Digital Health Age. Coming from the North East of England, Reece has an MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. Reach him on Twitter or email via:

'Digital nutrition start-up raises $8M' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions